Evolus Inc (EOLS)
13.30
+0.08
(+0.61%)
USD |
NASDAQ |
May 03, 16:00
13.30
0.00 (0.00%)
After-Hours: 20:00
Evolus Free Cash Flow: -35.64M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -35.64M |
September 30, 2023 | -46.25M |
June 30, 2023 | -62.74M |
March 31, 2023 | -70.49M |
December 31, 2022 | -87.85M |
September 30, 2022 | -87.12M |
June 30, 2022 | -101.27M |
March 31, 2022 | -64.27M |
December 31, 2021 | -34.36M |
September 30, 2021 | -27.49M |
June 30, 2021 | -9.797M |
March 31, 2021 | -40.11M |
December 31, 2020 | -61.01M |
Date | Value |
---|---|
September 30, 2020 | -75.51M |
June 30, 2020 | -86.84M |
March 31, 2020 | -107.37M |
December 31, 2019 | -97.95M |
September 30, 2019 | -92.89M |
June 30, 2019 | -72.95M |
March 31, 2019 | -43.50M |
December 31, 2018 | -25.67M |
September 30, 2018 | -14.66M |
June 30, 2018 | -12.30M |
March 31, 2018 | -9.845M |
December 31, 2017 | -13.22M |
Free Cash Flow Range, Past 5 Years
-107.37M
Minimum
Mar 2020
-9.797M
Maximum
Jun 2021
-66.42M
Average
-70.49M
Median
Mar 2023
Free Cash Flow Benchmarks
Viatris Inc | 2.325B |
Shockwave Medical Inc | 165.46M |
Perspective Therapeutics Inc | -37.98M |
Electromed Inc | 3.653M |
Xtant Medical Holdings Inc | -10.97M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 0.813M |
Cash from Investing (Quarterly) | -0.361M |
Cash from Financing (Quarterly) | 23.52M |
Free Cash Flow Per Share (Quarterly) | 0.0079 |
Free Cash Flow to Equity (Quarterly) | -24.81M |
Free Cash Flow to Firm (Quarterly) | 4.270M |
Free Cash Flow Yield | -4.71% |